These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23909066)

  • 1. Fertility preservation and breast cancer: A complex problem.
    Munster PN
    Oncology (Williston Park); 2013 Jun; 27(6):533-9. PubMed ID: 23909066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fertility preservation in breast cancer patients.
    El Hachem H; Atallah D; Grynberg M
    Future Oncol; 2014 Aug; 10(10):1767-77. PubMed ID: 25303056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Breast cancer and fertility: critical review, considerations and perspectives].
    This P
    Bull Cancer; 2008 Jan; 95(1):17-25. PubMed ID: 18230566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Premature ovarian failure after chemotherapy for breast cancer].
    Mathelin C; Brettes JP; Diemunsch P
    Bull Cancer; 2008 Apr; 95(4):403-12. PubMed ID: 18495569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fertility preservation options for women with malignancies.
    Marhhom E; Cohen I
    Obstet Gynecol Surv; 2007 Jan; 62(1):58-72. PubMed ID: 17176489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fertility after breast cancer.
    Christinat A; Pagani O
    Maturitas; 2012 Nov; 73(3):191-6. PubMed ID: 23020991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversies in preservation of ovary function and fertility in patients with breast cancer.
    Gerber B; Dieterich M; Müller H; Reimer T
    Breast Cancer Res Treat; 2008 Mar; 108(1):1-7. PubMed ID: 17457668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology.
    Lambertini M; Cinquini M; Moschetti I; Peccatori FA; Anserini P; Valenzano Menada M; Tomirotti M; Del Mastro L
    Eur J Cancer; 2017 Jan; 71():25-33. PubMed ID: 27940355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adjuvant chemotherapy for breast cancer and fertility: estimation of the impact, options of preservation and role of the oncologist].
    Mailliez A; Decanter C; Bonneterre J
    Bull Cancer; 2011 Jul; 98(7):741-51. PubMed ID: 21700552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can ovarian suppression with gonadotropin-releasing hormone analogs (GnRHa) preserve fertility in cancer patients?
    Rodriguez-Wallberg K; Turan V; Munster P; Oktay K
    Ann Oncol; 2016 Feb; 27(2):357. PubMed ID: 26609009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fertility preservation strategies in young women in case of breast cancer or hematologic malignancy].
    Decanter C; Robin G
    Gynecol Obstet Fertil; 2013 Oct; 41(10):597-600. PubMed ID: 24094596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study.
    Lambertini M; Fontana V; Massarotti C; Poggio F; Dellepiane C; Iacono G; Abate A; Miglietta L; Ferreccio C; Pescio MC; Conte B; Blondeaux E; Bighin C; D'Alonzo A; Vaglica M; Zanardi E; Boccardo F; Ballestrero A; Anserini P; Del Mastro L
    Breast; 2018 Oct; 41():51-56. PubMed ID: 30007268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer and fertility: an update.
    Ronn R; Holzer H
    Curr Opin Support Palliat Care; 2015 Sep; 9(3):285-93. PubMed ID: 26262832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing fertility needs of breast cancer patients: oncology perspective.
    Koczwara B
    Expert Rev Anticancer Ther; 2008 Aug; 8(8):1323-30. PubMed ID: 18699768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain.
    Turner NH; Partridge A; Sanna G; Di Leo A; Biganzoli L
    Ann Oncol; 2013 Sep; 24(9):2224-35. PubMed ID: 23709175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant therapy with GnRH agonists/tamoxifen in breast cancer should be a good council for patients with hormone receptor-positive tumours and wish to preserve fertility.
    Franco JG; Oliveira JB; Petersen CG; Mauri AL; Baruffi R; Cavagna M
    Med Hypotheses; 2012 Apr; 78(4):442-5. PubMed ID: 22284634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors.
    Knobf MT
    Oncologist; 2006 Feb; 11(2):96-110. PubMed ID: 16476831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Fertility Preservation for Young Women With Cancer.
    Smith KL; Gracia C; Sokalska A; Moore H
    Am Soc Clin Oncol Educ Book; 2018 May; 38():27-37. PubMed ID: 30231357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undetectable antimüllerian hormone levels and recovery of chemotherapy-induced ovarian failure in women with breast cancer on an oral aromatase inhibitor.
    Dieudonné AS; Vandenberghe J; Geerts I; Billen J; Paridaens R; Wildiers H; Neven P
    Menopause; 2011 Jul; 18(7):821-4. PubMed ID: 21326118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.